Get started
Author

Nayara Gusmão Tessarollo

Observed names: N.G. Tessarollo, Nayara G Tessarollo, Nayara G. Tessarollo, Nayara Gusmao Tessarollo, Nayara Gusmão Tessarollo, Nayara Tessarollo, Nayara G. Tessarollo, TESSAROLLO, N. G.
Observed institutions: Johns Hopkins University, Universidade Federal de Viçosa, Universidade de São Paulo, Johns Hopkins Medicine, Instituto do Câncer do Estado de São Paulo, Ministério da Saúde, Instituto Nacional de Câncer - INCA, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sidney Kimmel Comprehensive Cancer Center, Fiocruz Minas, Universidade Federal do Espírito Santo
ORCID: 0000-0003-4735-6971
Observed ORCID: 0000-0003-4735-6971
OpenAlex ID: A5086595456
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
2015 · Yu Yu, Stephanie Gaillard, et al. · Cancer Cell · 138
PDF
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome
2024 · Gabriela Rapozo Guimarães, Giovanna Resk Maklouf, et al. · Nature Communications · 94
Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines
2017 · Isabella dos Santos Guimarães, Taciane Ladislau-Magescky, et al. · Pharmacological Reports · 60
Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines
2014 · N.G. Tessarollo, J.M. Andrade, et al. · Parasitology International · 36
Clinical Applications and Immunological Aspects of Electroporation-Based Therapies
2021 · Jean Carlos dos Santos da Luz, Fernanda Antunes, et al. · Vaccines · 30
PDF
Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment
2021 · Taciane Barbosa Henriques, Diandra Zipinotti dos Santos, et al. · Aging · 29
PDF
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
2021 · Nayara Gusmão Tessarollo, Ana Carolina M. Domingues, et al. · Cancers · 24
PDF
Enzimas marcadoras de indução de resistência diferencialmente reguladas em soja resistente e suscetível à ferrugem-asiática-da-soja
2012 · Hebréia Oliveira Almeida, Meire de Oliveira Barbosa, et al. · Pesquisa Agropecuária Brasileira · 14
PDF
Targeting the PI3K/AKT/mTOR Pathway in Cancer Cells
2015 · Isabella S. Guimarães, Nayara G. Tessarollo, et al. · InTech eBooks · 13
PDF
Abstract 2571: Metformin inhibits proliferation and acts synergistically with paclitaxel and doxorubicin in triple negative breast cancer cell lines
2015 · Isabella S. Guimaraes, Nayara G. Tessarollo, et al. · Cancer Research · 8
Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
2022 · Otto Luiz Dutra Cerqueira, Fernanda Antunes, et al. · Frontiers in Molecular Biosciences · 6
PDF
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade
2025 · Ana Carolina M. Domingues, Soraia B. de Oliveira, et al. · Molecular Therapy Oncology · 5
Fitodefensivos em plantas medicinais: macromoléculas hidrofílicas de folhas de mil folhas (Achillea millefolium L.) inibem o crescimento in vitro de bactérias fitopatogênicas
2013 · N.G. Tessarollo, L.C. Carrijo, et al. · Revista Brasileira de Plantas Medicinais · 5
PDF
Exploring Latin America one cell at a time
2025 · Patricia A. Possik, David J. Adams, et al. · Cell · 4
PDF
Reporter system controlled by the involucrin promoter as a tool to follow epidermal differentiation
2022 · Myrian Thiago Pruschinski Fernandes, Jeniffer Farias dos Santos, et al. · Biochimie · 4
PDF
Abstract 2548: Metformin and everolimus act synergistically with paclitaxel against ovarian cancer
2015 · Nayara G. Tessarollo, Isabella S. Guimaraes, et al. · Cancer Research · 3
GWAS in Breast Cancer
2017 · Paulo C.M. Lyra-Junior, Nayara G. Tessarollo, et al. · InTech eBooks · 2
PDF
Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer
2025 · Nayara Gusmão Tessarollo, Isabella dos Santos Guimarães, et al. · Frontiers in Pharmacology · 1
PDF
Stable expression of shRNA for the control of recombinant adenovirus replication
2023 · M.V.G. Lana, F. Antunes, et al. · Brazilian Journal of Medical and Biological Research · 1
PDF
Metformin and mTOR Inhibitors: Allies against Ovarian and Breast Cancers
2017 · Isabella dos Santos Guimaraes, Nayara Gusmao Tessarollo, et al. · Journal of Carcinogenesis & Mutagenesis · 1
PATH-31 Molecular reclassification and mutational landscape of adult WHO grade 2 diffuse gliomas in a resource-limited setting
2026 · Carolina Fittipaldi Pessôa, Leandro Santos, et al. · Neuro-Oncology
TMIC-49 Integrated molecular and immune profiling of adult diffuse gliomas in a resource-constrained public oncology setting
2026 · Carolina Fittipaldi Pessôa, Nayara Tessarollo, et al. · Neuro-Oncology
Estudos mostram potencial da IA para aumentar precisão no prognóstico de câncer de ovário
2026 · Mariana Boroni, João Viola, et al. · The Conversation
Development and validation of a miRNA-based prognostic model for high-grade serous ovarian cancer: a retrospective cohort study
2026 · Cristiane Esteves Teixeira, Nayara Gusmão Tessarollo, et al. · The Lancet Regional Health - Americas
miROv Predict: assinatura de miRNAs com inteligência artificial para democratizar a estratificação prognóstica no câncer de ovário
2026 · Cristiane Esteves, Nayara Gusmão Tessarollo, et al.
Works count: 40
Citation count: 478
H-index: 9
I10-index: 9
Year
Topic
Type